Biotech Startup Wants Insulin More Affordable: How Can 'Biosimilar' Make a Difference? For those with diabetes, insulin is just like a part of the body that they need every time. However, patients are hampered by its price increase, so a startup decided to create its version of cheap insulin. by Joseph Henry
Healthy Living/Wellness FDA Advisory Panel Recommends Approval Of Remicade Knockoff by Rina Marie Doctor
Healthy Living/Wellness FDA Approves First 'Biosimilar' Drug Zarxio Paving Way For More Affordable Drugs by Sumit Passary